The new Express License service removes barriers to accessing this transformative gene editing technology for startups.An ...

An Express License provides fast, simple and affordable access to the CRISPR/Cas9 patent portfolio through ... including life sciences research tools, kits and reagents; discovery of novel targets ...

We recently compiled a list of the Top 11 CRISPR Stocks to Invest In. In this article, we are going to take a look at where ...

PCR products were then gel-purified using Zymoclean Gel DNA Recovery Kit (Zymo Research) and directly sequenced to evaluate off-target mutagenesis. Figure 1 Schematic diagram of CRISPR/Cas9 plant ...

Ongoing launch of CASGEVY® continues to gain momentum--2025 is poised to be a catalyst-rich year with key updates across several ...

The core components of CRISPR-based genome-editing therapies are bacterial proteins called nucleases that can stimulate ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Lehigh University bioenginering researcher Tomas Gonzalez-Fernandez recently secured funding through the National Science ...

In practice, automation makes it possible to edit, isolate, and screen thousands of clones for desired genetic changes made with CRISPR-Cas9 and transposase-based systems, ensuring that the best ...

CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and ...